IP Library Granted Patent US 8,244,369
Granted Patent B2
US 8,244,369 · App. 11/808,567 · Granted Aug 14, 2012

Device and method for treating skin with temperature control

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,244,369
App. No.
11/808,567
Granted
Aug 14, 2012
Kind
B2
Abstract

A method and system for heating a skin area surface of an individual from an initial temperature to a treatment temperature in a treatment time period exceeding 0.5 sec, where the treatment temperature is in the range of 40°-60° C. An RF generator provides a continuous wave RF voltage energy or a quasi-continuous wave RF voltage across first and second electrode, where at least the first electrode is associated with an applicator that is displaced over the skin surface. The system further includes a skin temperature measuring device or an applicator displacement speed measuring device; and a CPU that monitors a skin temperature or an applicator displacement speed. The CPU turns off the RF energy when the skin temperature is above a predetermined temperature or the displacement speed of the applicator is below a predetermined speed, in order to prevent overheating of the skin.

Claims (47)

1. A method for heating a tissue volume under the skin surface of an individual from an initial temperature to a treatment temperature in the range of 40 degrees to 60 degrees C, comprising:

(a) providing a continuous or a quasi-continuous wave RF energy across a first electrode and a second electrode, at least one of the electrodes being associated with an applicator;

(b) heating the tissue volume in a treatment time period exceeding 0.5 sec;

(c) displacing the applicator over the skin surface;

(d) monitoring a skin temperature;

(e) monitoring applicator displacement speed employing a motion sensor; and

(f) turning off or reducing the RF energy when the skin temperature is above a predetermined temperature or the displacement speed of the applicator is below a predetermined speed.

2. The method according to claim 1 wherein monitoring the skin temperature using an electronic or optical device.

3. The method according to claim 1 wherein said monitoring skin temperature comprises measuring skin impedance and calculating skin temperature based on said measured skin impedance.

4. The method according to claim 1 wherein the applicator motion is measured using a roller rolling over the skin surface when the applicator is displaced over the skin surface.

5. The method according to claim 1 wherein the applicator motion is measured by measuring the acceleration of the applicator.

6. The method according to claim 1 wherein the applicator motion is measured using an optical device.

7. The method according to claim 1 wherein two or more electrodes are associated with the applicator.

8. The method according to claim 1 wherein the power of said RF energy wave is in the range of 1-50 W.

9. The method according to claim 1 wherein the RF voltage has a frequency in the range of 0.2-50 MHz.

10. The method according to claim 1 further comprising directing optical energy to the skin surface.

11. The method according to claim 10 wherein at least part of the optical energy has a spectrum in the range of 400-1800 nm.

12. The method according to claim 11 wherein the sensible signal is sounding an alarm at a first pitch.

13. The method according to claim 10 wherein the optical energy has an energy power density in the range of 0.01 to 10 W/cm 2 .

14. The method according to claim 10 wherein a source of said optical energy is at least one selected from the group consisting of an incandescent lamp, a gas filled lamp, a LED and a laser.

15. The method according to claim 14 wherein the sensible signal is sounding an alarm at a second pitch or a visible signal.

16. The method according to claim 1 further comprising determining a wherein said monitoring skin temperature comprises measuring skin impedance and calculating heat distribution in the skin based upon one or more of the impedance measurements.

17. The method according to claim 1 further comprising generating a sensible signal if the skin temperature is below a predetermined temperature.

18. The method according to claim 1 further comprising generating a sensible signal if the skin temperature is above a predetermined temperature.

19. A method for heating a tissue volume under the skin surface of an individual from an initial temperature to a treatment temperature in the range of 40 degrees to 60 degrees C., comprising:

(a) providing a continuous wave or a quasi-continuous wave RF energy across a first electrode and a second electrode, at least one of the electrodes being associated with an applicator;

(b) heating said in a treatment time period exceeding 0.5 sec;

(c) displacing the applicator over the skin surface;

(d) monitoring a skin temperature;

(e) monitoring applicator motion by using at least one from the group consisting of:

a roller rolling over the skin surface when the applicator is displaced over the skin surface;

measuring the acceleration of the applicator; and

an optical device; and

(f) turning off or reducing the RF energy when the skin temperature is above a predetermined temperature or the displacement speed of the applicator is below a predetermined speed.

20. The method according to claim 19 , wherein said monitoring skin temperature comprises measuring skin impedance and calculating skin temperature based on said measured skin impedance.

21. The method according to claim 19 , wherein two or more electrodes are associated with the applicator.

22. The method according to claim 19 , wherein the power of said energy wave is in the range of 1-50 W.

23. The method according to claim 19 , wherein the RF voltage has a frequency in the range of 0.2-50 MHz.

24. The method according to claim 19 , further comprising directing optical energy to the skin surface.

25. The method according to claim 24 , wherein at least part of the optical energy has a spectrum in the range of 400-1800 nm.

26. The method according to claim 24 , wherein the optical energy has an energy power density in the range of 0.01 to 10 W/cm2.

27. The method according to claim 24 , wherein a source of said optical energy is at least one selected from the group consisting of an incandescent lamp, a gas filled lamp, a LED and a laser.

28. The method according to claim 19 , wherein said monitoring skin temperature comprises measuring skin impedance and calculating heat distribution in the skin based upon one or more of the impedance measurements.

29. The method according to claim 19 , further comprising generating a sensible signal if the skin temperature is below a predetermined temperature.

30. The method according to claim 29 , wherein the sensible signal is sounding an alarm at a first pitch.

31. The method according to claim 19 , further comprising generating a sensible signal if the skin temperature is above a predetermined temperature.

32. The method according to claim 31 , wherein the sensible signal is sounding an alarm at a second pitch or a visible signal.

Assignments (5)
NOTICE OF SUCCESSION OF AGENCY AT REEL/FRAME 059593/0269 Recorded May 29, 2026
From: BARCLAYS BANK PLC, AS PRIOR COLLATERAL AGENT
To: HSBC BANK USA, N.A., AS SUCCESSOR COLLATERAL AGENT
Reel/Frame 075648/0952 →
RELEASE (REEL 043925 / FRAME 0001) Recorded Apr 4, 2022
From: ING CAPITAL LLC
To: SYNERON MEDICAL LTD.; CANDELA CORPORATION; PRIMAEVA CORPORATION
Reel/Frame 059593/0131 →
SECURITY AGREEMENT Recorded Apr 4, 2022
From: CANDELA CORPORATION; SYNERON MEDICAL LTD.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 059593/0269 →
SECURITY AGREEMENT Recorded Sep 20, 2017
From: SYNERON MEDICAL LTD.; CANDELA CORPORATION; PRIMAEVA CORPORATION
To: ING CAPITAL LLC, AS COLLATERAL AGENT
Reel/Frame 043925/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2007
From: KREINDEL, MICHAEL
To: SYNERON MEDICAL LTD.
Reel/Frame 019808/0989 →